1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 7,480 | 7,580 | 23.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.05. | SMAIO Reported Revenue of €2.8 Million in the First Quarter of 2026, an Increase of 11% | 333 | Business Wire | Revenue in the United States reached a record quarterly high of €2.3 million (+21%), or $2.6 million (+35%)1 excluding currency effects
The United States accounts for nearly 80% of the... ► Artikel lesen | |
| S.M.A.I.O SA Aktie jetzt für 0€ handeln | |||||
| 11.05. | SMAIO Expands Its North American Scientific Advisory Board With a New Renowned Surgeon | 303 | Business Wire | Appointment of Dr. Jeffrey M. Hills, an orthopedic surgeon specializing in complex spinal conditions SMAIO's Scientific Advisory Board, now comprised of five members, is a key asset in... ► Artikel lesen | |
| 05.05. | SMAIO Announces that Portzamparc (BNP Paribas Group) has Initiated Coverage of its Stock with a Buy Rating | 431 | Business Wire | Regulatory News:
SMAIO (Software, Machines and Adaptive Implants in Orthopaedics Euronext Growth Paris, ISIN Code: FR0014005I80 Ticker: ALSMA), a French-American company specialized in complex... ► Artikel lesen | |
| 06.03. | SMAIO Announces a €3.6 Million Capital Increase to Support Its Long-Term Growth Momentum | 462 | Business Wire | Capital increase totaling €3.6 million gross through the issuance of shares with stock warrants (ABSAs) at a price of €7 per share
4 warrants will entitle the holder to subscribe for one... ► Artikel lesen | |
| 20.01. | SMAIO Reports 2025 Sales of €9.2m, Representing an Increase of +67% | 399 | Business Wire | U.S. sales rose by +138% to €7m, and by +160% to $7.9m (excluding currency effects).
Strong growth across North American centers that were already active in 2024 (+130%). 11 new... ► Artikel lesen | |
| 08.01. | SMAIO: 2026 Financial Calendar | 506 | Business Wire | Regulatory News:
SMAIO (Software, Machines and Adaptive Implants in Orthopaedics Euronext Growth Paris, ISIN: FR0014005I80 Ticker: ALSMA), a French-American player specialized in complex spine... ► Artikel lesen | |
| 06.01. | SMAIO Obtains €2.0m in Non-Dilutive Financing | 475 | Business Wire | €1.0m in the form of a 0% interest loan co-financed by the European Union, the Auvergne-Rhône-Alpes Region and Bpifrance, with a repayment deferral period of two and a half years €1.0m... ► Artikel lesen | |
| 19.12.25 | SMAIO Successfully Continues Its Think Tanks Focused on Promoting Its Innovative Solutions in the United States | 616 | Business Wire | New attendance record at the New York session, bringing together nearly 60 experts from the spine sector, including over 40 surgeons
Regulatory News:
SMAIO (Software, Machines and Adaptative... ► Artikel lesen | |
| 24.11.25 | SMAIO Appoints Matthieu Ville as Chief Commercial Officer to Accelerate Commercialization and Strengthen Its Leadership in Spinal Realignment | 356 | Business Wire | Matthieu Ville brings over 15 years of experience in medical marketing in the United States.
Regulatory News:
SMAIO (Software, Machines and Adaptative Implants in Orthopaedics- Euronext Growth... ► Artikel lesen | |
| 03.11.25 | SMAIO Adds a New High-Profile Member to Its Scientific Advisory Board in the United States | 348 | Business Wire | Appointment of Dr. Tenner Guillaume, Orthopaedic spine surgeon who specializes in spinal deformity at Gillette Children's Hospital (St. Paul, Minnesota). SMAIO's US scientific advisory board... ► Artikel lesen | |
| 22.10.25 | SMAIO Signs a New Distribution Agreement for Its Open Platform KEOPS-4ME With Orthofix in the U.S. | 552 | Business Wire | Orthofix is a global medical technology company focused on healing musculoskeletal pathologies The distribution arrangement is part of SMAIO's collaborative strategy aimed at deploying... ► Artikel lesen | |
| 14.10.25 | SMAIO Announces Strong First-Half 2025 Results and Robust Growth in Business Activity in the Third Quarter of 2025 | 353 | Business Wire | Strong sales growth in H1 2025: +126% to €5.0 million
Increase in gross margin in H1 2025 to 85% vs. 64% in H1 2024
Significant improvement in EBITDA (+96%) reaching break-even (vs.... ► Artikel lesen | |
| 24.09.25 | SMAIO Signs the First Major Distribution Agreement for Its Open Platform KEOPS-4ME with Highridge Medical in the U.S. | 452 | Business Wire | Highridge Medical is one of the world's largest privately held spine companies The partnership represents a key milestone in further expanding SMAIO's business activity in the U.S. and driving... ► Artikel lesen | |
| 16.07.25 | SMAIO Announces Significant Sales Increase in H1 2025 | 450 | Business Wire | Sales H1 2025: +126% to €5 million Acceleration of business activity in the United States (+360% to €3.8 million):
H1 2025 sales1 higher than full-year 2024 sales
More than... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 41,550 | +0,73 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für FMC von 38 auf 43 Euro angehoben, aber die Einstufung auf "Neutral" belassen. Analyst Richard Felton rechnet für... ► Artikel lesen | |
| GERRESHEIMER | 27,400 | +5,79 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
22.06.2026 / 11:08 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| DRAEGERWERK | 84,70 | +0,71 % | Dräger: 'Plötzliche Kurswechsel sind halt schlecht' | LÜBECK (dpa-AFX) - Der Unternehmer Stefan Dräger wünscht sich von der Politik klare Ansagen zu notwendigen Reformen in Deutschland. "Wir Unternehmer können uns ja anpassen und verändern", sagte Dräger... ► Artikel lesen | |
| HIMS & HERS HEALTH | 29,160 | -0,68 % | Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know | ||
| ALIGN TECHNOLOGY | 152,15 | +0,03 % | Align Technology board shakeup: Kevin Conroy to succeed retiring Chairman C. Raymond Larkin | ||
| HEALWELL AI | 0,500 | +1,63 % | HEALWELL AI informiert über Neuigkeiten aus dem Unternehmen: Annahme der Forschungsergebnisse aus provinzübergreifendem KI-Pilotprojekt beim AMIA-Symposium und Stärkung der Bilanz durch SpaceX-Beteiligung | - HEALWELL hat erfolgreich ein Pilotprojekt zur Bewertung seiner auf DARWEN basierenden KI-Lösungen SMART Summary und SMART Search in mehreren kanadischen Provinzen
abgeschlossen. Das... ► Artikel lesen | |
| ORGANON | 11,790 | +0,55 % | Organon and Henlius launch Prolia and Xgeva biosimilars in Canada | ||
| LIMES SCHLOSSKLINIKEN | 550,00 | -0,90 % | Financially attractive expansion into Italy; PT Up: Limes Schlosskliniken signs binding deal to acquire Villa Boccella ... | LIMES signed a preliminary yet binding agreement to acquire the operating company of the "Villa Boccella" estate in Lucca, Tuscany. In our view, that significantly increases the attractiveness of LIMES'... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 4,490 | 0,00 % | Jim Cramer Says Clover Health Was a Good Speculative Pick But Still Prefers UnitedHealth and CVS | ||
| BONESUPPORT | 18,300 | -0,65 % | Bonesupport Holding AB: BONESUPPORT HOLDING AB (publ) - publishes Q1 2026 interim report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the first quarter 2026.
"Solid start to 2026 - strong growth... ► Artikel lesen | |
| FRESENIUS | 39,900 | +0,91 % | DAX leicht unter Druck - Auto1, BMW, Fresenius, Munich Re und Vonovia im Check | Der DAX steht zum Handelsstart leicht unter Druck. Nach zwei gescheiterten Anläufen auf die 25.000-Punkte-Marke prägt Vorsicht vor dem US-Zinsentscheid am Abend das Geschehen. Gewinnmitnahmen bei US-Technologiewerten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,520 | +0,06 % | Großer Schritt geplant: Siemens Energy: Diese Abspaltung könnte zum nächsten Kursturbo werden | © Foto: Frank Rumpenhorst - dpaEin möglicher Verkauf der Industriesparte könnte bei Siemens Energy mehr Wert freisetzen, als der Kurs bisher zeigt. Analysten glauben: Das könnte erst der Anfang sein.Siemens... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 66,83 | -0,55 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BETA BIONICS | 13,670 | -0,22 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| HEARTSCIENCES | 2,750 | +55,37 % | Fortitude Mining Holdings, Inc. and HeartSciences Inc. Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets | FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (Nasdaq: HSCS) ("HeartSciences")... ► Artikel lesen |
Das Unternehmen S.M.A.I.O SA kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 7,480 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu S.M.A.I.O SA finden Sie auf Wallstreet Online.